VRTX vs. LLY
Compare and contrast key facts about Vertex Pharmaceuticals Incorporated (VRTX) and Eli Lilly and Company (LLY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VRTX or LLY.
Correlation
The correlation between VRTX and LLY is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
VRTX vs. LLY - Performance Comparison
Loading data...
Key characteristics
VRTX:
-0.02
LLY:
-0.03
VRTX:
0.29
LLY:
0.27
VRTX:
1.04
LLY:
1.04
VRTX:
0.10
LLY:
-0.00
VRTX:
0.26
LLY:
-0.00
VRTX:
9.11%
LLY:
12.85%
VRTX:
28.58%
LLY:
38.42%
VRTX:
-91.77%
LLY:
-68.27%
VRTX:
-15.11%
LLY:
-20.68%
Fundamentals
VRTX:
$111.55B
LLY:
$658.30B
VRTX:
-$3.83
LLY:
$12.61
VRTX:
2.59
LLY:
1.10
VRTX:
10.05
LLY:
13.43
VRTX:
6.76
LLY:
40.75
VRTX:
$11.09B
LLY:
$49.00B
VRTX:
$9.54B
LLY:
$40.03B
VRTX:
-$228.00M
LLY:
$16.67B
Returns By Period
In the year-to-date period, VRTX achieves a 8.93% return, which is significantly higher than LLY's -1.52% return. Over the past 10 years, VRTX has underperformed LLY with an annualized return of 13.11%, while LLY has yielded a comparatively higher 28.65% annualized return.
VRTX
8.93%
-9.72%
-5.81%
-0.45%
8.75%
13.11%
LLY
-1.52%
3.27%
1.88%
-1.11%
38.32%
28.65%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VRTX vs. LLY — Risk-Adjusted Performance Rank
VRTX
LLY
VRTX vs. LLY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Vertex Pharmaceuticals Incorporated (VRTX) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
VRTX vs. LLY - Dividend Comparison
VRTX has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.74%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VRTX Vertex Pharmaceuticals Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LLY Eli Lilly and Company | 0.74% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.95% | 2.46% | 2.77% | 2.37% | 2.84% |
Drawdowns
VRTX vs. LLY - Drawdown Comparison
The maximum VRTX drawdown since its inception was -91.77%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for VRTX and LLY. For additional features, visit the drawdowns tool.
Loading data...
Volatility
VRTX vs. LLY - Volatility Comparison
The current volatility for Vertex Pharmaceuticals Incorporated (VRTX) is 13.52%, while Eli Lilly and Company (LLY) has a volatility of 22.29%. This indicates that VRTX experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
VRTX vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between Vertex Pharmaceuticals Incorporated and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VRTX vs. LLY - Profitability Comparison
VRTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported a gross profit of 2.41B and revenue of 2.77B. Therefore, the gross margin over that period was 86.9%.
LLY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a gross profit of 10.50B and revenue of 12.73B. Therefore, the gross margin over that period was 82.5%.
VRTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported an operating income of 630.10M and revenue of 2.77B, resulting in an operating margin of 22.8%.
LLY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported an operating income of 5.41B and revenue of 12.73B, resulting in an operating margin of 42.5%.
VRTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported a net income of 646.30M and revenue of 2.77B, resulting in a net margin of 23.3%.
LLY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a net income of 2.76B and revenue of 12.73B, resulting in a net margin of 21.7%.